Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
NCT05266417
This study is recruiting at 4 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study will be evaluating the safety and efficacy of insulin and glutathione in subjects with Parkinson's Disease compared to placebo.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Parkinson Disease
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 30 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Gateway Institute for Brain Research
- Last updated on ClinicalTrials.gov
- July 22, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 4
- Institute for Neuroimmune Medicine · Davie, FL
- Las Mercedes Medical Research · Hialeah, FL
- NextGen Research Group · Miami, FL
- Charter Research · The Villages, FL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.